A Study of the Safety and Efficacy of AGN-214868 in Patients With Postherpetic Neuralgia

Status:
Completed

Trial end date:
2012-01-01

Target enrollment:

Participant gender:

This study will evaluate the safety and efficacy of AGN-214868 in patients with postherpetic neuralgia (PHN) - nerve pain.

Phase 2

Allergan